The Respiratory Syncytial Virus Infections- Market Insights, Epidemiology and Market Forecast-2020 report provides an overview of the disease, epidemiology and global market trends for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and middle east countries (Jordan, Saudi Arabia, Kuwait, Oman, UAE, Tunisia, Turkey, Egypt, Lebanon and Qatar). According to DelveInsight, the market for preventive therapies to treat RSV Infections will experience modest annual growth over the 2010-2020 forecast period, as market size increase from $148.9 million to 777.49 million in European five countries.
Respiratory syncytial virus (RSV) is a virus that causes infections of the lungs and respiratory tract. It's so common that most children have been infected with the virus by age 2.RSV can cause upper respiratory infections (such as cold, fever and otitis media) and lower respiratory tract infections (such as pneumonia, bronchiolitis, tracheobronchitis). RSV also affects adults and can also become serious in older adult with heart and lung diseases, or anyone with a very weak immune system (immune compromised).
Key Coverage and Benefits:
• The report will help in developing business strategies by understanding the trends shaping and driving the global Respiratory Syncytial Virus Infections
• Identifying patient populations in the global Respiratory Syncytial Virus Infections market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Respiratory Syncytial Virus Infections therapeutics in each of the markets covered.
• To understand the future market competition in the global Respiratory Syncytial Virus Infections therapeutics market and Insightful review of the key market drivers and barriers.
Scope of the Report:
• Report covers the disease overview including etiology, pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Middle Eastern Countries and rest of the word from 2010-2020.
• It also provides Market size of Respiratory syncytial virus (RSV) for United States, EU5, Middle Eastern Countries from 2010 and forecasted Market size to 2020
'
Table of Contents
Respiratory Syncytial Virus Infection
Disease overview:
Pathophysiology:
Symptoms of disease:
Etiology of disease
Diagnosis of disease
Treatment of disease
Overview of Marketed drugs
Synagis Description
Mechanism of Action
Pharmacokinetics Properties
Marketed Details
United States
Europe
Patent Information
Patents Details
Historical and Forecasted sales of marketed molecules in the Global Respiratory Syncytial Virus (RSV) Infections Market
Global Epidemiology of Respiratory Syncytial Virus (RSV) Infections Forecasted to 2020
Global Historical & Forecasted Market size (2010-2020)
Global Market size of United States (US) (2010-2020)
Global Market size of Europe (EU5) (2010-2020)
Global Market Size by Geography in Europe
Market size of Germany (2010-2020)
Market size of United Kingdom (2010-2020)
Market size of France (2010-2020)
Market size of Italy (2010-2020)
Market size of Spain (2010-2020)
Global Market Size in Middle Eastern Countries
Global Market Size in Middle Eastern Countries by Geography
Market size of Jordan (2010-2020)
Market size of Saudi Arabia (2010-2020)
Market size of Kuwait (2010-2020)
Market size of Oman (2010-2020)
Market size of UAE (2010-2020)
Market size of Tunisia (2010-2020)
Market size of Turkey (2010-2020)
Market size of Egypt (2010-2020)
Market size of Lebanon (2010-2020)
Market size of Qatar (2010-2020)
Appendix
Report Methodology
Consulting Services
Disclaimer
Report Purchase Options
About DelveInsight
List of Tables
Table 1:Synagis, Description
Table 2: Synagis, Marketed Details for United States (US)
Table 3: Synagis, Marketed Details for Europe
Table 4: Synagis, Patent Number Specific Patent Expiry in US (Year), 2015
Table 5: Synagis, Patent 1 Details for US
Table 6: Synagis, Patent 2 Details for US
Table 7: Synagis, Patent 3 Details for US
Table 8: Synagis, Patent 4 Details for US
Table 9: Synagis, Patent 5 Details for US
Table 10: Synagis, Patent 6 Details for US
Table 11: Synagis, Patent 7 Details for US
Table 12: Synagis, Patent 8 Details for US
Table 13: Respiratory Syncytial Virus (RSV) Infections Synagis Drug Sales (USD Millions), (2014-2020)
Table 14: Global Epidemiology of Respiratory Syncytial Virus (RSV) Infections (2012-2020)
Table 15: Respiratory Syncytial Virus (RSV) Infections United States Market Size (USD Millions), (2010-2020)
Table 15: Respiratory Syncytial Virus (RSV) Infections Germany Market Size (USD Millions), (2010-2020)
Table 16: Respiratory Syncytial Virus (RSV) Infections United Kingdom Market Size (USD Millions), (2010-2020)
Table 17: Respiratory Syncytial Virus (RSV) Infections France Market Size (USD Millions), (2010-2020)
Table 18: Respiratory Syncytial Virus (RSV) Infections Italy Market Size (USD Millions), (2010-2020)
Table 19: Respiratory Syncytial Virus (RSV) Infections Spain Market Size (USD Millions), (2010-2020)
Table 20: Respiratory Syncytial Virus (RSV) Infections Jordan Market Size (USD Millions), (2010-2020)
Table 21: Respiratory Syncytial Virus (RSV) Infections Saudi Arabia Market Size (USD Millions), (2010-2020)
Table 22: Respiratory Syncytial Virus (RSV) Infections Kuwait Market Size (USD Millions), (2010-2020)
Table 23: Respiratory Syncytial Virus (RSV) Infections Oman Market Size (USD Millions), (2010-2020)
Table 24: Respiratory Syncytial Virus (RSV) Infections UAE Market Size (USD Millions), (2010-2020)
Table 25: Respiratory Syncytial Virus (RSV) Infections Tunisia Market Size (USD Millions), (2010-2020)
Table 26: Respiratory Syncytial Virus (RSV) Infections Turkey Market Size (USD Millions), (2010-2020)
Table 27: Respiratory Syncytial Virus (RSV) Infections Egypt Market Size (USD Millions), (2010-2020)
Table 28: Respiratory Syncytial Virus (RSV) Infections Lebanon Market Size (USD Millions), (2010-2020)
Table 29: Respiratory Syncytial Virus (RSV) Infections Qatar Market Size (USD Millions), (2010-2020)
List of Figures
Figure 1: Respiratory Syncytial Virus (RSV) Infections Synagis Drug Sales (USD Millions), (2014-2020)
Figure 2: Global Epidemiology of Respiratory Syncytial Virus (RSV) Infections (2012-2020)
Figure 3: Respiratory Syncytial Virus (RSV) Infections United States Market Size (USD Millions), (2010-2020)
Figure 3: Respiratory Syncytial Virus (RSV) Infections EU5 Market Size (USD Millions), (2010-2020)
Figure 4: Respiratory Syncytial Virus (RSV) Infections Germany Market Size (USD Millions), (2010-2020)
Figure 5: Respiratory Syncytial Virus (RSV) Infections United Kingdom Market Size (USD Millions), (2010-2020)
Figure 6: Respiratory Syncytial Virus (RSV) Infections France Market Size (USD Millions), (2010-2020)
Figure 7: Respiratory Syncytial Virus (RSV) Infections Italy Market Size (USD Millions), (2010-2020)
Figure 8: Respiratory Syncytial Virus (RSV) Infections Spain Market Size (USD Millions), (2010-2020)
Figure 9: Respiratory Syncytial Virus (RSV) Infections Middle Eastern Countries Market Size (USD Millions), (2010-2020)
Figure 10: Respiratory Syncytial Virus (RSV) Infections Jordan Market Size (USD Millions), (2010-2020)
Figure 11: Respiratory Syncytial Virus (RSV) Infections Saudi Arabia Market Size (USD Millions), (2010-2020)
Figure 12: Respiratory Syncytial Virus (RSV) Infections Kuwait Market Size (USD Millions), (2010-2020)
Figure 13: Respiratory Syncytial Virus (RSV) Infections Oman Market Size (USD Millions), (2010-2020)
Figure 14: Respiratory Syncytial Virus (RSV) Infections UAE Market Size (USD Millions), (2010-2020)
Figure 15: Respiratory Syncytial Virus (RSV) Infections Tunisia Market Size (USD Millions), (2010-2020)
Figure 16: Respiratory Syncytial Virus (RSV) Infections Turkey Market Size (USD Millions), (2010-2020)
Figure 17: Respiratory Syncytial Virus (RSV) Infections Egypt Market Size (USD Millions), (2010-2020)
Figure 18: Respiratory Syncytial Virus (RSV) Infections Lebanon Market Size (USD Millions), (2010-2020)
Figure 19: Respiratory Syncytial Virus (RSV) Infections Qatar Market Size (USD Millions), (2010-2020)
Medimmune
Novavax
Regeneron Pharmaceuticals
AstraZeneca
Valeant Pharmaceuticals
